Island Pharmaceuticals Limited (ASX:ILA)
Australia · Delayed Price · Currency is AUD 0.3700
0.00 (0.00%)
Mar 31, 2026, 4:10 PM AEST
Island Pharmaceuticals Market Cap
Island Pharmaceuticals has a market cap or net worth of 109.37 million as of March 31, 2026. Its market cap has increased by 255.39% in one year.
Market Cap
109.37M
Enterprise Value
102.50M
Revenue
62.85K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.37
Market Cap Chart
Since April 13, 2021, Island Pharmaceuticals's market cap has increased from 42.51M to 109.37M, an increase of 157.28%. That is a compound annual growth rate of 20.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 109.37M | -5.47% |
| Dec 31, 2025 | 115.69M | 274.76% |
| Dec 31, 2024 | 30.87M | 299.86% |
| Dec 29, 2023 | 7.72M | -48.65% |
| Dec 28, 2022 | 15.03M | -27.45% |
| Dec 31, 2021 | 20.72M | -51.25% |
| Apr 13, 2021 | 42.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 133.02M |
| Amplia Therapeutics | 123.14M |
| Actinogen Medical | 118.52M |
| Paradigm Biopharmaceuticals | 115.68M |
| Botanix Pharmaceuticals | 90.94M |
| Alterity Therapeutics | 87.00M |
| Arovella Therapeutics | 82.09M |
| LTR Pharma | 72.71M |